Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11789891 | 0.75 | SPHK1 (0.31) | — | |
| SCHEMBL27294772 | 0.74 | ALDH1A1 (0.41) | HTTALDH1A1 | |
| SCHEMBL27416061 | 0.71 | ARG1 (0.37) | — | |
| Carbamic Acid SCHEMBL30778297 | 0.68 | OPRM1 (0.32) | — | |
| SCHEMBL13448934 | 0.67 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL14532980 | 0.66 | CYP1A2 (0.31) | — | |
| SCHEMBL10532989 | 0.65 | ARG1 (0.51) | — | |
| SCHEMBL7522829 | 0.65 | KDM4E (0.35) | — | |
| SCHEMBL14533014 | 0.65 | KDM4E (0.35) | — | |
| SCHEMBL2906586 | 0.65 | ARG1 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063701-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC (JP) | 2004-04-01 | — | — | US | claimed |
| US-20020147195-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC. (JP) | 2002-10-10 | — | — | US | claimed |
| US-20020019533-A1 | PIPERIDINE DERIVATIVES AND ANTI-PLATELET AGENTS CONTAINING THE SAME | MAKINO SHINGO (JP) | 2002-02-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019533-A1 | PIPERIDINE DERIVATIVES AND ANTI-PLATELET AGENTS CONTAINING THE SAME | HTR2A, PDGFRA, PDGFRB | HTT 1134/4885ALDH1A1 2071/4885 |
| US-20020147195-A1 | Piperidine derivatives and anti-platelet agents containing the same | HTR2A, PDGFRA, PDGFRB | HTT 1134/4885ALDH1A1 2071/4885 |
| US-20040063701-A1 | Piperidine derivatives and anti-platelet agents containing the same | HTR2A, PDGFRA, PDGFRB | HTT 1134/4885ALDH1A1 2071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.